middle.news
ReNerve Accelerates Sales and Clinical Wins Amid Global Expansion
6:04am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
ReNerve Accelerates Sales and Clinical Wins Amid Global Expansion
6:04am on Monday 2nd of June, 2025 AEST
Key Points
Q3 FY25 sales rose 39% to A$75,000
Clinical study shows significant pain reduction and patient satisfaction with NervAlign® Nerve Cuff
US sales and marketing leadership strengthened with new VP appointment
Expanded global footprint via partnerships in Mexico, Thailand, Hong Kong, and India
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RENERVE (ASX:RNV)
OPEN ARTICLE